{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:09:58Z","timestamp":1778454598669,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,10]]},"DOI":"10.7759\/cureus.108603","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:52:05Z","timestamp":1778453525000},"source":"Crossref","is-referenced-by-count":0,"title":["Cystic Fibrosis With No Known Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation and a Negative Newborn Screening Test: A Case Report"],"prefix":"10.7759","author":[{"given":"Rachana","family":"Subbanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.2298\/SARH1204244R","article-title":"Cystic fibrosis","volume":"140","author":"Radlovi\u0107 N","year":"2012","unstructured":"Radlovi\u0107 N. Cystic fibrosis. Srp Arh Celok Lek. 2012, 140:244-9.","journal-title":"Srp Arh Celok Lek"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.10.008","article-title":"Contemporary cystic fibrosis incidence rates in Canada and the United States","volume":"22","author":"Stephenson AL","year":"2023","unstructured":"Stephenson AL, Swaleh S, Sykes J, et al.. Contemporary cystic fibrosis incidence rates in Canada and the United States. J Cyst Fibros. 2023, 22:443-9. 10.1016\/j.jcf.2022.10.008","journal-title":"J Cyst Fibros"},{"key":"ref3","unstructured":"Newborn screening laboratory. (2026). Accessed. March 14, 2026: https:\/\/dhhr.wv.gov\/ols\/labs\/Pages\/NewbornScreening.aspx."},{"key":"ref4","unstructured":"Office of maternal child and family health\/newborn screening. (2024). Accessed. March 14, 2026: https:\/\/www.wvdhhr.org\/nbms\/diseases\/Cystic_Fibrosis.asp."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.01.006","article-title":"Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation","volume":"14","author":"Bodewes FA","year":"2015","unstructured":"Bodewes FA, Verkade HJ, Taminiau JA, Borowitz D, Wilschanski M. Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation. J Cyst Fibros. 2015, 14:169-77. 10.1016\/j.jcf.2015.01.006","journal-title":"J Cyst Fibros"},{"key":"ref6","article-title":"Sweat testing","author":"Zubair M","year":"2025","unstructured":"Zubair M, Schmidt H, Sharma G. Sweat testing. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-117-8_6","article-title":"Nasal potential difference measurements to assess CFTR ion channel activity","volume":"741","author":"Rowe SM","year":"2011","unstructured":"Rowe SM, Clancy JP, Wilschanski M. Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol. 2011, 741:69-86. 10.1007\/978-1-61779-117-8_6","journal-title":"Methods Mol Biol"},{"key":"ref8","unstructured":"Clinical care guide for diagnosis of cystic fibrosis. (2021). Accessed. March 14, 2026: https:\/\/www.cff.org\/sites\/default\/files\/2021-10\/Clinical-Care-Guide-for-Diagnosis-of-CF.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/1806-3713\/e20180062","article-title":"False-negative newborn screening result for immunoreactive trypsinogen: a major problem in children with chronic lung disease","volume":"45","author":"Lumertz MS","year":"2019","unstructured":"Lumertz MS, Rispoli T, Rosa KM, Pinto LA. False-negative newborn screening result for immunoreactive trypsinogen: a major problem in children with chronic lung disease. J Bras Pneumol. 2019, 45:e20180062. 10.1590\/1806-3713\/e20180062","journal-title":"J Bras Pneumol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0286","article-title":"The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis","volume":"128","author":"Dunn CT","year":"2011","unstructured":"Dunn CT, Skrypek MM, Powers AL, Laguna TA. The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis. Pediatrics. 2011, 128:e446-9. 10.1542\/peds.2010-0286","journal-title":"Pediatrics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429849-cystic-fibrosis-with-no-known-cystic-fibrosis-transmembrane-conductance-regulator-cftr-mutation-and-a-negative-newborn-screening-test-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:52:07Z","timestamp":1778453527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429849-cystic-fibrosis-with-no-known-cystic-fibrosis-transmembrane-conductance-regulator-cftr-mutation-and-a-negative-newborn-screening-test-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.108603","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,10]]}}}